Charles Samson, M.D.

Profile picture
Associate Professor of Pediatrics, Gastroenterology, Hepatology and Nutrition
Fellowship Program Director, Pediatric Gastroenterology, Hepatology and Nutrition
Director, Washington University Pediatric and Adolescent Inflammatory Bowel Disease Center at St Louis Children's Hospital
Gastroenterology, Hepatology and Nutrition

phone: (314) 454-6173

Clinical Interests

Pediatric inflammatory bowel disease and general pediatric gastrointestinal illness


  • BS, Highest Distinction and Highest Honors, University of North Carolina at Chapel Hill1998
  • MD, Thesis Honors, University of Washington2003


  • Pediatric Residency, Univeristy of North Carolina at Chapel Hill/NC Children's Hospital2003 - 2006
  • Pediatric Gastroenterology Fellowship, Cincinnati Children's Hospital Medical Center2006 - 2009
  • Advanced Improvement Methods Workshop, Cincinnati Children's Hospital Medical Center2014 - 2015
  • Pediatric Leadership Development Program, Washington University School of Medicine2016 - 2016
  • Academic Medical Leadership Program for Physicians & Scientists, Washington University School of Medicine, Washington University Olin Business School, & BJC Healthcare2018 - 2018

Licensure and Board Certification

  • NC, NC Training License 2003
  • OH, Ohio Training Certificate 2006
  • American Board of Pediatrics; General Pediatrics 2006
  • OH, Ohio Medical License 2009
  • American Board of Pediatrics; Pediatric Gastroenterology 2009
  • MO, Missouri Medical License 2011
  • AR, Arkansas Medical License 2016


  • David L Stern Award; Department of Chemistry; University of North Carolina at Chapel Hill1997
  • Phi Beta Kappa; University of North Carolina at Chapel Hill1997
  • Highest Distinction Graduate; University of North Carolina at Chapel Hill1998
  • Highest Honor's Thesis in Chemistry; University of North Carolina at Chapel Hill1998
  • Venable Medal; Department of Chemistry; University of North Carolina at Chapel Hill1998
  • Medical Thesis Honors; University of Washington School of Medicine2002
  • Fellowship to Faculty Transition Award; Foundation of the American Gastroenterological Association2009
  • Pediatric Loan Repayment Award; National Institutes of Health2009
  • Procter Scholar Award; Cincinnati Children's Hospital Medical Center2009
  • Poster of Distinction, Digestive Disease Week2011

Recent Publications view all (19)

Publication Co-Authors

  1. Accuracy of the medication list in the electronic health record-implications for care, research, and improvement. J Am Med Inform Assoc. 2018;25(7):909-912. PMID:29771350 
  2. The Use of Concomitant Immunomodulators with Adalimumab Therapy in Pediatric Crohn's Disease J Clin Cell Immunol. 2018;9(1):e pub. 
  3. Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience. Inflamm Bowel Dis. 2017;23(12):2104-2108. PMID:29140940 
  4. Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis J Rheum. 2017;44(11):1624-31. PMID:28916545 
  5. Application of Conjoint Analysis to Improve Reliability of Dietician Consultation in Pediatric Celiac Disease Pediatr Qual Saf. 2017;2(4):epub. 
  6. Remission in Pediatric Inflammatory Bowel Disease Correlates With Prescription Refill Adherence Rates. J Pediatr Gastroenterol Nutr. 2017;64(4):575-579. PMID:27299424 
  7. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2012;55(6):679-88. PMID:22699837 
  8. Budesonide use in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2012;55(2):200-4. PMID:22258289 
  9. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics. 2012;129(4):e1030-41. PMCID:PMC3313634  PMID:22412030 
  10. Granulocyte-macrophage colony stimulating factor blockade promotes ccr9(+) lymphocyte expansion in Nod2 deficient mice. Inflamm Bowel Dis. 2011;17(12):2443-55. PMCID:PMC3111853  PMID:21381154 
  11. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study. Am J Gastroenterol. 2011;106(5):981-7. PMID:21224840 
  12. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis. 2011;17(1):56-61. PMID:20645322 
  13. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury. Gut. 2010;59(8):1066-78. PMCID:PMC4296557  PMID:20584783 
  14. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology. 2009;136(4):1261-71, e1-3. PMID:19230854 
  15. Primary cirrhotic hepatocytes resist TGFbeta-induced apoptosis through a ROS-dependent mechanism. J Hepatol. 2004;40(6):942-51. PMID:15158334 
  16. TNF alpha-induced hepatocyte apoptosis is associated with alterations of the cell cycle and decreased stem loop binding protein. Surgery. 2004;135(6):619-28. PMID:15179368 
  17. Cirrhotic hepatocytes exhibit decreased TGFbeta growth inhibition associated with downregulated Smad protein expression. Biochem Biophys Res Commun. 2004;313(3):546-51. PMID:14697224 
  18. NFkappaB inhibition decreases hepatocyte proliferation but does not alter apoptosis in obstructive jaundice. J Surg Res. 2003;114(2):110-7. PMID:14559434 
  19. Transforming growth factor-beta1 induces hepatocyte apoptosis by a c-Jun independent mechanism. Surgery. 2002;132(3):441-9. PMID:12324757 
Last updated: 08/23/2018
© 2019 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130